Loading...
Pharmacokinetics, Biodistribution, and Radiation Dosimetry for (89)Zr-Trastuzumab in Patients with Esophagogastric Cancer
Trastuzumab with chemotherapy improves clinical outcomes in patients with human epidermal growth factor receptor 2 (HER2)–positive esophagogastric adenocarcinoma (EGA). Despite the therapeutic benefit, responses are rarely complete, and most patients develop progression. To our knowledge, this is th...
Na minha lista:
| Udgivet i: | J Nucl Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Society of Nuclear Medicine
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5750520/ https://ncbi.nlm.nih.gov/pubmed/28637800 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.117.194555 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|